Search research articles
Contact Us
Filters
Showing results (81-90 of 151) with videos related to
Page
of 16
Sort By:
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society
|
May 2, 2025
Absolute lymphocyte count trajectory predicts clinical outcome in severely injured patients
Lena-Marie Reichardt, Bianca Hindelang, Lönna Süberkrüb, et al.
Frontiers in Immunology
|
April 8, 2025
Dynamic functional assessment of T cells reveals an early suppression correlating with adverse outcome in polytraumatized patients
Tobias Jooss, Katharina Maier, Lena-Marie Reichardt, et al.
Shock (Augusta, Ga.)
|
October 30, 2025
Quantifying Nuance within Sepsis-Associated Immune Suppression toward Diagnostic Certainty
Charles C Caldwell, Robert Maile, Monty B Mazer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Amilcar Flores-Morales, Tobias B Bergmann, Charlotte Lavallee, et al.
Journal of Immunological Methods
|
August 15, 2024
Development and optimization of a diluted whole blood ELISpot assay to test immune function
Ricardo F Ungaro, Julie Xu, Tamara A Kucaba, et al.
Frontiers in Immunology
|
October 29, 2024
Surviving septic patients endotyped with a functional assay demonstrate active immune responses
Adam D Price, Ellen R Becker, Evan L Barrios, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γELISpot: A Multicenter, Prospective Observational Study
Evan A Barrios, Monty B Mazer, Patrick McGonagill, et al.
Neurology
|
October 6, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Steve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 29, 2022
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.
JCI Insight
|
December 15, 2023
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
Evan L Barrios, Monty B Mazer, Patrick W McGonagill, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 151) with videos related to
Sort By:
Page
of 16
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society
|
May 2, 2025
Absolute lymphocyte count trajectory predicts clinical outcome in severely injured patients
Lena-Marie Reichardt, Bianca Hindelang, Lönna Süberkrüb, et al.
Frontiers in Immunology
|
April 8, 2025
Dynamic functional assessment of T cells reveals an early suppression correlating with adverse outcome in polytraumatized patients
Tobias Jooss, Katharina Maier, Lena-Marie Reichardt, et al.
Shock (Augusta, Ga.)
|
October 30, 2025
Quantifying Nuance within Sepsis-Associated Immune Suppression toward Diagnostic Certainty
Charles C Caldwell, Robert Maile, Monty B Mazer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Amilcar Flores-Morales, Tobias B Bergmann, Charlotte Lavallee, et al.
Journal of Immunological Methods
|
August 15, 2024
Development and optimization of a diluted whole blood ELISpot assay to test immune function
Ricardo F Ungaro, Julie Xu, Tamara A Kucaba, et al.
Frontiers in Immunology
|
October 29, 2024
Surviving septic patients endotyped with a functional assay demonstrate active immune responses
Adam D Price, Ellen R Becker, Evan L Barrios, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γELISpot: A Multicenter, Prospective Observational Study
Evan A Barrios, Monty B Mazer, Patrick McGonagill, et al.
Neurology
|
October 6, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Steve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 29, 2022
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.
JCI Insight
|
December 15, 2023
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
Evan L Barrios, Monty B Mazer, Patrick W McGonagill, et al.
Page
of 16